Corporate Banner
Satellite Banner
ADME Tox
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - September 2013


SMi - Geriatric Safe Medicines Summit

16 Sep 2013 - 17 Sep 2013 - London, UK



Bookmark and Share


Clinical research in geriatric patient populations requires the adaptation of traditional clinical procedures in research studies. A relatively new area of research, geriatric patient studies requires a collaboration between many different stakeholders within this field to identify and overcome the challenges involved in recruiting, treating and retaining study subjects. Join SMi as we look to address these issues with new and innovative thinking and approaches that are being applied to geriatric clinical studies.

KEY REASONS TO ATTEND

Discover the benefits of performing clinical trials in older people

Identify the key challenges and considerations when conducting clinical trials in older people

Address reasons for clinical trial retention difficulties

Discuss how modelling and simulation along with new patient reporting systems support clinical trials in older people

Explore new market gaps and discover new market strategy

Focus on the EMA geriatric medicines strategy

KEYNOTE SPEAKERS INCLUDE:

Solange Rohou, Director of Regulatory Affairs, AstraZeneca

Barbro Westerholm, Member of Parliament, Sweden, Liberal Party

Florian Von Raison, Global Programme Head, Novartis

Nina Barnett, Consultant Pharmacologist, Northwest London's Hospital NHS Trust

Philippe Guillet, Strategy Head, Sanofi

Michael Richardson, VP International and QPPV EU GPV&E, Bristol Myers Squibb

Eva Bredberg, Director Global Clinical Pharmacology, AstraZeneca

Anthea Tinker, Professor of Social Gerontology, Kings College London

Visit our website here: http://www.smi-online.co.uk/geriatricsummit13.asp

Alternatively, contact: Jonathan Collins on +44 (0)20 7827 6734 or email: jcollins@smi-online.co.uk

Academic & Group discounts available



Further information
Scientific News
Retractable Protein Nanoneedles
The ability to control the transfer of molecules through cellular membranes is an important function in synthetic biology; a new study from researchers at Harvard’s Wyss Institute for Biologically Inspired Engineering and Harvard Medical School (HMS) introduces a novel mechanical method for controlling release of molecules inside cells.
Iron in the Blood Could Cause Cell Damage
Concentrations of iron similar to those delivered through standard treatments can trigger DNA damage within 10 minutes, when given to cells in the laboratory.
Advancing Synthetic Biology
Living systems rely on a dizzying variety of chemical reactions essential to development and survival. Most of these involve a specialized class of protein molecules — the enzymes.
Insights into the Function of the Main Class of Drug Targets
About thirty percent of all medical drugs such as beta-blockers or antidepressants interact with certain types of cell surface proteins called G protein coupled receptors.
Honey’s Potential to Save Lives
The healing powers of honey have been known for thousands of years.
Muscles on-a-Chip
This study may help explain why stem cell-based therapies have so far shown limited benefits for heart attack patients in clinical trials.
3-D Printed Lifelike Liver Tissue for Drug Screening
A team led by engineers at the University of California, San Diego has 3D-printed a tissue that closely mimics the human liver's sophisticated structure and function. The new model could be used for patient-specific drug screening and disease modeling.
Envigo Rat Models Proven to be Susceptible to Intra-Vaginal HSV-2 Infection and Protectable
Scientific findings establish the effectiveness of new approach to investigate the protective effects of vaccine candidates and anti-viral microbodies and to study asymptomatic primary genital HSV-2 infection.
Valvena, GSK Sign New R&D Collaboration
Valneva to supply process development services for EB66® -based Influenza vaccines.
Food Triggers Creation of Regulatory T Cells
IBS researchers document how normal diet establishes immune tolerance conditions in the small intestine.
Scroll Up
Scroll Down
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!